Alkaline phosphatase =< 2.5 x ULN (CTCAE v 3.0 grade 0-1)
164.0
Alkaline phosphatase within upper limits of institutional normal within 14 days prior to study entry
285.0
Alkaline phosphatase less than or equal to 2.5 x ULN (CTCAE grade 1)
128.0
Alkaline phosphatase =< 3 x ULN
52.0
Alkaline phosphatase =< 1.5 x IULN within 28 days prior to registration
1900.0
Serum alkaline phosphatase (ALP) > 2 x ULN
45.0
Alkaline phosphatase less than or equal to 2.5 x ULN
540.0
Alkaline phosphatase =< 1.5 x institutional ULN, within 21 days prior to registration
924.0
Alkaline phosphatase (ALP) =< 2.5 x ULN measured within 28 days prior to randomization
1500.0
Patients must have alkaline phosphatase =< 2.5 x IULN within 14 days prior to registration
44.0
Alkaline phosphatase =< 2 x ULN (=< 5 x ULN for patients with known liver involvement and =< 7 x ULN for patients with known bone involvement)
300.0
Alkaline phosphatase =< 2 x ULN (=< 5 x ULN for patients with known liver involvement and =< 7 x ULN for patients with known bone involvement)
400.0
Within 6 weeks prior to randomization: Alkaline phosphatase must be =< 2.5 x ULN for the lab
990.0
Alkaline phosphatase =< 2.5 x ULN, within 14 days prior to registration
147.0
Alkaline phosphatase must be =< 3 x ULN for the lab within 28 days before randomization
348.0
Alkaline phosphatase =< 2.5 x ULN (=< 5 x ULN for patients with documented liver involvement or bone metastases)
35.0
Alkaline phosphatase =< 2 x IULN
148.0
Alkaline phosphatase =< 2.5 x ULN (=< 5 x ULN for patients with documented liver involvement or bone metastases)
72.0
Alkaline phosphatase =< 2.5 x ULN
60.0
Alkaline phosphatase =< 2.5 x ULN
22.0
Alkaline phosphatase =< 2.5 x IULN, obtained within 28 days prior to step 2 registration
1000.0
Alkaline phosphatase =< 2 x ULN (=< 5 x ULN for patients with documented liver involvement or bone metastases)
78.0
